This is a good result. Congratulations to Mr Glennan and the Tesserent team. If they can sustain this for another quarter, I expect to see a substantial appreciation in share price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025